HOME
|
CONTACT
|
SITEMAP
HOME
CORPORATE
VISION
MANAGEMENT TEAM
BOARD OF DIRECTORS
CLINICAL ADVISORY BOARD
SCIENTIFIC ADVISORY BOARD
CORPORATE GOVERNANCE
TECHNOLOGY
NTx®-265 (Stroke)
NTx®-428 (Brain Trauma)
NTx®-488 (Multiple Sclerosis)
PUBLICATIONS
MEDIA CENTRE
GLOSSARY
INVESTORS
STOCK INFORMATION
FINANCIAL REPORTS
STROKE MARKET
SHAREHOLDER SERVICES
INVESTOR CONTACT
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
TSX - Venture:
SSS
INVESTOR RELATIONS
STOCK INFORMATION
FINANCIAL REPORTS
STROKE MARKET
SHAREHOLDER SERVICES
INVESTOR CONTACT
FINANCIAL REPORTS
Annual Reports
2009
Letter to Shareholders
Audited FS
Audited MD & A
2008
Letter to Shareholders
Audited FS
Audited MD & A
2007
Annual Report
Audited FS
Audited MD & A
2006
Annual Report
Audited FS
Audited MD & A
2005
Annual Report
Audited FS
Audited MD & A
2004
Audited FS
Audited MD & A
2010
QUARTERLY REPORTS
First Quarter FS
First Quarter MD & A
2009
QUARTERLY REPORTS
First Quarter FS
First Quarter MD & A
Second Quarter MD & A
Second Quarter FS
Third Quarter FS
Third Quarter MD & A
2008
QUARTERLY REPORTS
First Quarter FS
First Quarter MD & A
Second Quarter MD & A
Second Quarter FS
Third Quarter FS
Third Quarter MD & A
2007
QUARTERLY REPORTS
First Quarter FS
First Quarter MD & A
Second Quarter FS
Second Quarter MD & A
Third Quarter FS
Third Quarter MD & A
2006
QUARTERLY REPORTS
First Quarter FS
First Quarter MD & A
Second Quarter FS
Second Quarter MD & A
Third Quarter FS
Third Quarter MD & A
2005
QUARTERLY REPORTS
First Quarter FS
First Quarter MD & A
Second Quarter FS
Second Quarter MD & A
Third Quarter FS
Third Quarter MD & A
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade:
0.065
Change:
+8.33%
Volume:
243549
Date:
9/3/2010
Time:
3:48pm
Note: Quotes are delayed. For informational purposes only.
LETTER TO SHAREHOLDERS
+
2009 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved
Home
|
Site Map
|
Terms Of Use
|
Contact Us